Litigation Details for Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. (D. Del. 2020)
✉ Email this page to a colleague
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-08-20 |
Court | District Court, D. Delaware | Date Terminated | 2023-05-04 |
Cause | 35:1 Patent Infringement | Assigned To | Mitchell S. Goldberg |
Jury Demand | None | Referred To | |
Patents | 10,493,028 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
Details for Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-06-10 | 137 | limited to the Patents-in-Suit, i.e., United States Patent Nos. 10,493,028 (“’028 Patent”), 10,688,046…The “‘028 Patent” means United States Patent No. 10,493,028. 15. The “‘046 Patent” means United…(as to the ’028 Patent and the ’046 Patent) and July 7, 2021 (as to the ’948 Patent). Azurity also …(as to the ’028 Patent and the ’046 Patent) and July 7, 2021 (as to the ’948 Patent). Azurity also …issue date of the patent, and will include the patent term adjustment on the patent. Any request for reconsideration | External link to document | |
2020-08-20 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,493,028 B2. (mal) (Entered…August 2020 4 May 2023 1:20-cv-01094 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-06-11 | 54 | Notice of Service | Preliminary Invalidity Contentions for U.S. Patent Nos. 10,493,028 and 10,668,046 filed by Alkem Laboratories…August 2020 4 May 2023 1:20-cv-01094 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |